Investigational New Drugs

Type

Journal

Сокращенное название на английском и других языках, кроме русского

Invest. New Drugs

Publisher

Springer New York LLC

Codes

ISSN: 0167-6997

Date of creation

19.10.2018

Date of change

19.10.2018

Short link

https://repository.rudn.ru/en/recordsources/recordsource/1449/

List of records

Display:

ANTI-CANCER ACTIVITY OF ULTRA-SHORT SINGLE-STRANDED POLYDEOXYRIBONUCLEOTIDES

Article

Fursov Valentin V., Vedenkin Alexander S., Stovbun Sergey V., Bukhvostov Alexander A, Zlenko Dmitry V., Stovbun Ivan S., Silnikov Vladimir N., Kuznetsov Dmitry A.

Investigational New Drugs. Springer New York LLC. Vol. 41. 2023. P. 153-161

METHIONINE GAMMA LYASE FROM CLOSTRIDIUM SPOROGENES INCREASES THE ANTICANCER EFFECT OF DOXORUBICIN IN A549 CELLS AND HUMAN CANCER XENOGRAFTS

Article

Pokrovsky V.S., Bazhenov S.V., Bulushova N.V., Zavilgelsky G.B., Kotova V.Y., Manukhov I.V., Yu Anisimova N., Zh Davydov D.

Investigational New Drugs. Springer New York LLC. 2018. P. 1-9

Page 1 of 1. Items from 1 to 2 of 2

Other record sources

ICNC-FSKD 2017 - 13TH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY

Conference proceedings

13th International Conference on Natural Computation, Fuzzy Systems and Knowledge Discovery, ICNC-FSKD 2017. Institute of Electrical and Electronics Engineers Inc..

PROCEEDINGS - 2018 URAL SYMPOSIUM ON BIOMEDICAL ENGINEERING, RADIOELECTRONICS AND INFORMATION TECHNOLOGY, USBEREIT 2018

Conference proceedings

2018 Ural Symposium on Biomedical Engineering, Radioelectronics and Information Technology, USBEREIT 2018. Institute of Electrical and Electronics Engineers Inc..